Benefit of Elevation of HDL-C in Women

Cardiovascular Outcomes Clinical Trial

Official title:
Benefit of Elevation of HDL-cholesterol/Triglyceride Lowering on Cardiovascular Outcomes in Women

Status Completed

Clinical Trial Summary

The combination of HDL-C elevation, lowering of triglycerides and further LDL-C reduction accomplished by the addition of niacin to statin medication would improve endothelial function as compared to LDL-C reduction alone in patients with and without coronary artery disease and the combination of low HDL-C/high triglycerides.

The combination of lipid lowering therapy would have beneficial effects on markers of inflammation. These benefits would be particularly evident in women.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cardiovascular Outcomes

Clinical Trial Details

NCT number	NCT01921010
Study type	Interventional
Source	Cedars-Sinai Medical Center
Contact
Status	Completed
Phase	Phase 4
Start date	June 2003
Completion date	June 2005

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04125212` - Air Pollution and Cardio-metabolic Health
Completed	`NCT02601352` - Air Pollution and Cardiometabolic Study
Recruiting	`NCT03206593` - Serum Lipids and Glucose Levels in Relation to CVD Outcomes in Patients With Ischemic Heart Failure	N/A
Withdrawn	`NCT02058875` - Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring	Phase 4
Completed	`NCT03899675` - Impact of Caffeine Intake on Autonomic Parameters in the Exercise of Strength	N/A